1. Signaling Pathways
  2. Cell Cycle/DNA Damage
  3. Topoisomerase

Topoisomerase

Topoisomerase

Topoisomerases are enzymes that regulate the overwinding or underwinding of DNA. The winding problem of DNA arises due to the intertwined nature of its double-helical structure. Topoisomerases are isomerase enzymes that act on the topology of DNA. Type I topoisomerase cuts one strand of a DNA double helix, relaxation occurs, and then the cut strand is reannealed. Type I topoisomerases are subdivided into two subclasses: type IA topoisomerases, which share many structural and mechanistic features with the type II topoisomerases, and type IB topoisomerases, which utilize a controlled rotary mechanism. Type II topoisomerase cuts both strands of one DNA double helix, pass another unbroken DNA helix through it, and then reanneal the cut strands. This class is also split into two subclasses: type IIA and type IIB topoisomerases, which possess similar structure and mechanisms.

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-15142
    Doxorubicin hydrochloride
    Inhibitor 99.90%
    Doxorubicin hydrochloride (Hydroxydaunorubicin hydrochloride; ADR), a cytotoxic anthracycline antibiotic, is an anti-cancer chemotherapy agent. Doxorubicin hydrochloride is a potent human DNA topoisomerase I and topoisomerase II inhibitor with IC50s of 0.8 μM and 2.67 μM, respectively. Doxorubicin hydrochloride reduces basal phosphorylation of AMPK and its downstream target acetyl-CoA carboxylase. Doxorubicin hydrochloride induces apoptosis and autophagy.
    Doxorubicin hydrochloride
  • HY-13629
    Etoposide
    Inhibitor 99.94%
    Etoposide (VP-16; VP-16-213) is an anti-cancer chemotherapy agent. Etoposide inhibits topoisomerase II, thus stopping DNA replication. Etoposide induces cell cycle arrest, apoptosis and autophagy.
    Etoposide
  • HY-13631A
    Exatecan mesylate
    Inhibitor 99.97%
    Exatecan mesylate (DX8951f) is a DNA topoisomerase I inhibitor, with an IC50 of 2.2 μM (0.975 μg/mL). Exatecan mesylate can be used in cancer research.
    Exatecan mesylate
  • HY-13631D
    Dxd
    Inhibitor 99.43%
    Dxd (Exatecan derivative for ADC) is a potent DNA topoisomerase I inhibitor, with an IC50 of 0.31 μM, used as a conjugated drug of HER2-targeting ADC (DS-8201a).
    Dxd
  • HY-13704
    SN-38
    Inhibitor 99.89%
    SN-38 is an active metabolite of the Topoisomerase I inhibitor Irinotecan. SN-38 inhibits DNA and RNA synthesis with IC50s of 0.077 and 1.3 μM, respectively. SN-38 is a payload of sacituzumab govitecan (HY -132254).
    SN-38
  • HY-13631AS
    Exatecan-d5 mesylate
    Inhibitor 99.82%
    c is deuterium labeled Exatecan mesylate (HY-13631A). Exatecan mesylate is a DNA topoisomerase I inhibitor, with an IC50 of 2.2 μM (0.975 μg/mL). Exatecan mesylate can be used in cancer research.
    Exatecan-d<sub>5</sub> mesylate
  • HY-164792
    DBCO-PEG3-VC-Exatecan
    Inhibitor
    DBCO-PEG3-VC-Exatecan (compound 25) is a Drug-Linker Conjugate for ADC. DBCO-PEG3-VC-Exatecan contains the ADC linker (DBCO-PEG3-VC) and a DNA topoisomerase I inhibitor Exatecan (HY-13631).
    DBCO-PEG3-VC-Exatecan
  • HY-159783
    Mal-Exatecan
    Inhibitor
    Mal-Exatecan is a Mal (Maleimide) modified Exatecan (HY-13631), a DNA topoisomerase I (topoisomerase I) inhibitor.
    Mal-Exatecan
  • HY-16560
    Camptothecin
    Inhibitor 99.86%
    Camptothecin (CPT), a kind of alkaloid, is a DNA topoisomerase I (Topo I) inhibitor with an IC50 of 679 nM. Camptothecin (CPT) exhibits powerful antineoplastic activity against colorectal, breast, lung and ovarian cancers, modulates hypoxia-inducible factor-1α (HIF-1α) activity by changing microRNAs (miRNA) expression patterns in human cancer cells.
    Camptothecin
  • HY-16562
    Irinotecan
    Inhibitor 99.97%
    Irinotecan ((+)-Irinotecan) is a topoisomerase I inhibitor, preventing religation of the DNA strand by binding to topoisomerase I-DNA complex.
    Irinotecan
  • HY-13631
    Exatecan
    Inhibitor 99.93%
    Exatecan (DX-8951) is a DNA topoisomerase I inhibitor, with an IC50 of 2.2 μM (0.975 μg/mL), and can be used in cancer research.
    Exatecan
  • HY-13768A
    Topotecan hydrochloride
    Inhibitor 99.89%
    Topotecan Hydrochloride (SKF 104864A Hydrochloride) is a Topoisomerase I inhibitor with potent antineoplastic activities.
    Topotecan hydrochloride
  • HY-13062
    Daunorubicin hydrochloride
    Inhibitor 99.67%
    Daunorubicin (Daunomycin) hydrochloride is a topoisomerase II inhibitor with potent anti-tumor activity. Daunorubicin hydrochloride inhibits DNA and RNA synthesis. Daunorubicin hydrochloride is a cytotoxin that inhibits cancer cell viability and induces apoptosis and necrosis. Daunorubicin hydrochloride is also an anthracycline antibiotic. Daunorubicin hydrochloride can be used in the research of infection and variety of cancers, including leukemia, non-Hodgkin lymphomas, Ewing's sarcoma, Wilms' tumor.
    Daunorubicin hydrochloride
  • HY-13502
    Mitoxantrone
    Inhibitor 99.58%
    Mitoxantrone is a potent topoisomerase II inhibitor. Mitoxantrone also inhibits protein kinase C (PKC) activity with an IC50 of 8.5 μM. Mitoxantrone induces apoptosis of B-CLL (B-chronic lymphocytic leukaemia) cells. Mitoxantrone shows antitumor activity. Mitoxantrone also has anti-orthopoxvirus activity with EC50s of 0.25 μM and and 0.8 μM for cowpox and monkeypox, respectively.
    Mitoxantrone
  • HY-18258
    Berberine chloride
    Inhibitor 99.92%
    Berberine chloride is an alkaloid that acts as an antibiotic. Berberine chloride induces reactive oxygen species (ROS) generation and inhibits DNA topoisomerase. Antineoplastic properties.
    Berberine chloride
  • HY-13624A
    Epirubicin hydrochloride
    Inhibitor 99.16%
    Epirubicin hydrochloride (4'-Epidoxorubicin hydrochloride), a semisynthetic L-arabino derivative of doxorubicin, has an antineoplastic agent by inhibiting Topoisomerase. Epirubicin hydrochloride inhibits DNA and RNA synthesis. Epirubicin hydrochloride is a Forkhead box protein p3 (Foxp3) inhibitor and inhibits regulatory T cell activity.
    Epirubicin hydrochloride
  • HY-16562A
    Irinotecan hydrochloride
    Inhibitor 99.89%
    Irinotecan hydrochloride ((+)-Irinotecan hydrochloride) is a topoisomerase I inhibitor mainly used to treat colon cancer and rectal cancer.
    Irinotecan hydrochloride
  • HY-141598
    Datopotamab deruxtecan
    Inhibitor 99.54%
    Datopotamab deruxtecan (DS-1062; Dato-DXd) is a trophoblast cell surface antigen 2 (TROP2)-directed antibody-drug conjugate (ADC). Datopotamab deruxtecan has a potent antitumor activity.
    Datopotamab deruxtecan
  • HY-42487
    Exatecan Intermediate 1
    Inhibitor 99.99%
    Exatecan Intermediate 1 (compound 6) is an intermediate of Exatecan (HY-13631). Exatecan is a DNA topoisomerase I inhibitor with anticancer effects.
    Exatecan Intermediate 1
  • HY-B0330
    Levofloxacin
    Inhibitor 99.92%
    Levofloxacin ((-)-Ofloxacin) is an orally active antibiotic and is active against both Gram-positive and Gram-negative bacteria. Levofloxacin inhibits the DNA gyrase and topoisomerase IV. Levofloxacin can be used for chronic periodontitis, airway inflammation and BK Viremia research. Levofloxacin shows anti-orthopoxvirus activity.
    Levofloxacin
Cat. No. Product Name / Synonyms Application Reactivity

Topoisomerase

Topo I

Topo II

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.

Topoisomerase Inhibitors & Agonists
Product NameTopoisomeraseTopo ITopo IIPurity    
Doxorubicin hydrochloride 
Topoisomerase I, IC50: 0.8 μM
Topoisomerase II, IC50: 2.67 μM
99.90%
Etoposide  
Topoisomerase II
99.94%
Dxd 
Topoisomerase I, IC50: 0.31 μM
 99.43%
SN-38 
Topoisomerase I
 99.89%
Camptothecin 
Topoisomerase I, IC50: 679 nM
 99.86%
Irinotecan 
Topoisomerase I
 99.97%
Topotecan hydrochloride 
Topoisomerase I
 99.89%
Daunorubicin hydrochloride  
Topoisomerase II
99.67%
Mitoxantrone  
Topoisomerase II
99.58%
Epirubicin hydrochloride
Topoisomerase
  99.16%
Irinotecan hydrochloride 
Topoisomerase I
 99.89%
Datopotamab deruxtecan 
Topoisomerase I
 99.54%
Levofloxacin
TOPO IV
  99.92%
Idarubicin hydrochloride  
Topoisomerase II
99.94%
Betulinic acid 
Topoisomerase I, IC50: 5 μM
 99.06%
Mitoxantrone dihydrochloride  
Topoisomerase II
99.55%
β-Lapachone 
Topoisomerase I
 99.96%
Dxd-d5 
Topoisomerase I, IC50: 0.31 μM
 98.84%
Teniposide  
Topoisomerase II
99.00%
Pirarubicin  
Topoisomerase II
99.61%
Irinotecan hydrochloride trihydrate 
Topoisomerase I
 99.89%
Belotecan hydrochloride 
Top1
 99.88%
Etoposide phosphate  
Topoisomerase II
PNU-159682 
Topoisomerase I
 98.25%
Aclacinomycin A 
Topoisomerase I
Topoisomerase II
99.30%
Aldoxorubicin  
Topoisomerase II
Aurintricarboxylic acid  
Topoisomerase II
Banoxantrone dihydrochloride  
Topoisomerase II
99.46%
Nalidixic acid
Topoisomerase
  99.97%
Proscillaridin A 
Topoisomerase I, IC50: 30 nM
Topoisomerase II, IC50: 100 nM
99.74%
Levofloxacin hydrate
TOPO IV
  99.93%
Pirarubicin Hydrochloride  
Topoisomerase II
99.14%
Pixantrone  
Topoisomerase II
98.75%
(S)-10-Hydroxycamptothecin 
Topoisomerase I
 99.38%
Ellipticine  
Topoisomerase II
99.56%
Bisantrene  
Topoisomerase II
98.08%
Amsacrine  
Topoisomerase II
99.95%
Gatifloxacin  
Topoisomerase II, IC50: 36.7 μM
99.69%
MC-GGFG-AM-(10Me-11F-Camptothecin) 
Topoisomerase I
 98.06%
Ellipticine hydrochloride  
Topoisomerase II
99.34%
PluriSIn #2  
topoisomerase II alpha
≥98.0%
Hycanthone 
Topoisomerase I
Topoisomerase II
99.97%
Amonafide  
Topoisomerase II
99.92%
Voreloxin Hydrochloride  
Topoisomerase II
99.58%
Coralyne chloride 
Topoisomerase I
 98.30%
Amsacrine hydrochloride  
Topoisomerase II
99.98%
Amrubicin  
Topoisomerase II
≥98.0%
9-Aminocamptothecin 
Topoisomerase I
 98.89%
TAS-103 dihydrochloride 
Topoisomerase I
Topoisomerase II
98.87%
Genz-644282 
Topoisomerase I
 99.53%
MC-DOXHZN hydrochloride  
Topoisomerase II
98.04%
Chloroquinoxaline sulfonamide  
topoisomerase II alpha
topoisomerase II beta
99.06%
Indotecan 
Topoisomerase I
 ≥98.0%
(±)-10-Hydroxycamptothecin 
Topoisomerase I
 99.57%
Nalidixic acid sodium salt
Topoisomerase
  99.83%
Flumequine  
Topoisomerase II, IC50: 15 μM
Daun02
Topoisomerase
  98.72%
Intoplicine 
Topoisomerase I
Topoisomerase II
98.36%
Gimatecan 
Topoisomerase I
 99.28%
Gatifloxacin hydrochloride  
Topoisomerase II, : 36.7 μM
99.94%
Lurtotecan 
Topoisomerase I
 98.01%
Isodiospyrin 
Topoisomerase I
 99.77%
(±)-Evodiamine 
Top1
 99.74%
Karenitecin 
Topoisomerase I
 98.02%
LMP744 hydrochloride 
Top1
 99.70%
Levofloxacin hydrochloride
TOPO IV
  ≥98.0%
Groenlandicine 
Topoisomerase I
 99.87%
Indimitecan 
Top1
 98.30%
Namitecan 
Topoisomerase I
 99.25%
ARN-21934  
topoisomerase II alpha
topoisomerase II beta
98.08%
Podocarpusflavone A 
Topoisomerase I, IC50: 119.425 μM
 99.62%
LMP517 
Topoisomerase I
Topoisomerase II
99.58%
Garenoxacin Mesylate hydrate
TOPO IV, IC50: 1.5-2.5 μg/mL
  99.78%
LMP744 
Top1
 98.85%
Aclacinomycin A hydrochloride 
Topoisomerase I
Topoisomerase II
Topoisomerase I inhibitor 8 
Topoisomerase I
 
Elomotecan hydrochloride 
Topoisomerase I
Topoisomerase II
Epirubicin
Topoisomerase
  98.45%
Topoisomerase II inhibitor 20 TFA  
Topoisomerase II, IC50: 0.98 μM
Zabofloxacin hydrochloride 
Topoisomerase I
Topoisomerase II
99.54%
9-Hydroxyellipticine hydrochloride  
Topoisomerase II
≥99.0%
SW044248 
Topoisomerase I
 99.60%
Topotecan 
Topoisomerase I
 
Doxorubicin 
Topoisomerase I, IC50: 0.8 μM
Topoisomerase II, IC50: 2.67 μM
Daunorubicin  
Topoisomerase II
Topoisomerase II inhibitor 20  
Topoisomerase II, IC50: 0.98 μM
98.44%
CH-0793076 
Topoisomerase I, IC50: 2.3 μM
 
AQ4  
Topoisomerase II
BNS-22  
topoisomerase II alpha, IC50: 2.8 μM (in human)
topoisomerase II beta, IC50: 0.42 μM (in human)
99%
Seconeolitsine 
Topoisomerase I, IC50: 17 μM
 
Edotecarin 
Topoisomerase I, IC50: 50 nM
 98.39%
CH-0793076 TFA 
Topoisomerase I, IC50: 2.3 μM
 98.71%
Zabofloxacin 
Topoisomerase I
Topoisomerase II
98.02%
Amrubicin hydrochloride  
Topoisomerase II
Pixantrone free base  
Topoisomerase II
Voreloxin  
Topoisomerase II
99.26%
TAS-103 
Topoisomerase I
Topoisomerase II
MC-DOXHZN  
Topoisomerase II
Topotecan hydrochloride hydrate 
Topoisomerase I
 
Etoposide phosphate disodium  
Topoisomerase II
Idarubicin  
Topoisomerase II
Gatifloxacin sesquihydrate  
Topoisomerase II, IC50: 36.7 μM
Rebeccamycin 
Topoisomerase I
 
Mitoxantrone diacetate  
Topoisomerase II
CBX-12 
Topoisomerase I
 
Daunorubicin citrate  
Topoisomerase II
Antitumor agent-63 
Top1
 
Silatecan 
Topoisomerase I
 
Topoisomerase II inhibitor 9  
Topoisomerase II, IC50: 0.97 μM
Topo I/COX-2-IN-1 
Topoisomerase I, IC50: 4.42 μM
 
Bimolane  
Topoisomerase II
T-2513 hydrochloride 
Topoisomerase I
 
TOPOI/PARP-1-IN-2 
Top1, IC50: 46.2 nM
 
Topo I/COX-2-IN-2 
Topoisomerase I, IC50: 0.90 μM
 
Topoisomerase II inhibitor 11  
Topoisomerase II, IC50: 2.89 μM
CS1  
topoisomerase II alpha
T-2513 
Topoisomerase I
 
Razoxane  
Topoisomerase II
99.16%
Topoisomerase IIα-IN-3  
topoisomerase II alpha
Heliquinomycin 
Topoisomerase I
Topoisomerase II
Topoisomerase II/EGFR-IN-1  
Topoisomerase II
VcMMAE-Deruxtecan 
Topoisomerase I
 
Anticancer agent 75  
Topoisomerase II
CP-67804  
Topoisomerase II
DTS-108 
Top1
 
Pixantrone hydrochloride  
Topoisomerase II
Topoisomerase II inhibitor 4  
Topoisomerase II
Topoisomerase IIα-IN-6  
topoisomerase II alpha, IC50: 0.67 μM
Topoisomerase IIα-IN-2  
topoisomerase II alpha
topoisomerase II beta
Topoisomerase IIα-IN-4  
topoisomerase II alpha, IC50: 3.8 μM
topoisomerase II beta, IC50: 10.1 μM
ZLHQ-5f 
Top1
 
3-Fluoro-evodiamine glucose 
Topoisomerase I
Topoisomerase II
Topo I-IN-1 
Topoisomerase I
 
Topoisomerase I/II inhibitor 6 
Topoisomerase I, IC50: 4.77 μM
Topoisomerase II, IC50: 15 μM
EGFR-IN-116  
Topoisomerase II, IC50: 19.74 μM
Top/HDAC-IN-2 
Top1
Topoisomerase II
Anti-MRSA agent 7
TOPO IV, IC50: 0.059 μM (E. coli )
TOPO IV, IC50: 0.341 μM (S. aureus)
  
Topoisomerase II inhibitor 18  
Topoisomerase II, IC50: 7.5 μM
Topoisomerase I inhibitor 17 
Top1
 
Elomotecan 
Topoisomerase I
Topoisomerase II
Topoisomerase II inhibitor 5  
Topoisomerase II
LE01 
Topoisomerase I
 
HSP90-IN-13
Topoisomerase-2, IC50: 25.85 nM
  
Topoisomerase I inhibitor 2 
Topoisomerase I, IC50: 0.58 μM
 
iNOS/TopoI-IN-1 
Topoisomerase I, Ki: 2.72 μM
 
Topoisomerase II inhibitor 10  
Topoisomerase II, IC50: 7.45 μM
Salvicine  
Topoisomerase II, IC50: 3 μM
Topoisomerase IV inhibitor 1
TOPO IV, IC50: 0.23 μM
  
Topoisomerase II inhibitor 13  
Topoisomerase II
99.26%
EGFR-IN-57  
topoisomerase II beta, IC50: 0.13 μM
Topoisomerase IIα-IN-1  
topoisomerase II alpha
topoisomerase II beta
Huanglongmycin N 
Topoisomerase I, EC50: 14 μM
 
Topoisomerase IIα-IN-8  
topoisomerase II alpha
Tilatamig samrotecan 
Topoisomerase I
 
Deruxtecan-Eribulin 
Topoisomerase I
 
CP-67015  
Topoisomerase II
Tapcin 
Topoisomerase I, IC50: 203 nM
Topoisomerase II, IC50: 71 nM
Topoisomerase I inhibitor 12 
Topoisomerase I
 
Topoisomerase II inhibitor 17  
Topoisomerase II, IC50: 0.23 μM
Topoisomerase I/II inhibitor 2 
Topoisomerase I
Topoisomerase II
Topo I/II-IN-2 
Topoisomerase I
Topoisomerase II
Saintopin 
Topoisomerase I
Topoisomerase II
Intoplicine dimesylate 
Topoisomerase I
Topoisomerase II
98.28%
Topoisomerase IV inhibitor 2
TOPO IV, IC50: 0.35 μM
  
Topoisomerase II inhibitor 7  
topoisomerase II alpha, IC50: 3.19 μM
Topoisomerase I/II inhibitor 7 
Topoisomerase I
Topoisomerase II
Topoisomerase IIα-IN-7  
topoisomerase II alpha, IC50: 7.7 μM
Niranthin
Topoisomerase
  
Epolactaene  
Topoisomerase II, IC50: 10 μM
Topoisomerase I inhibitor 3 
Topoisomerase I
 
Topoisomerase II inhibitor 19  
Topoisomerase II, IC50: 0.34 μM
Corydamine 
Topoisomerase I
Topoisomerase II
TP0480066  
Topoisomerase II
AZD5099  
Topoisomerase II
Topoisomerase I inhibitor 16 
Topoisomerase I
 
TP3011 
Topoisomerase I
 
Topoisomerase II inhibitor 8  
Topoisomerase II, IC50: 0.52 μM
Topoisomerase I/II inhibitor 3 
Topoisomerase I
Topoisomerase II
Gatifloxacin mesylate  
Topoisomerase II, IC50: 36.7 μM
Topoisomerase IIα-IN-5  
topoisomerase II alpha
Bakuchicin  
Topoisomerase II, IC50: 404 μM
Thaspine acetate 
Topoisomerase I
Topoisomerase II
Antibacterial agent 229
TOPO IV, IC50: 10.88 μM
  
(-)-BO 2367  
Topoisomerase II
8-Chloro-ATP tetrasodium  
Topoisomerase II
Garenoxacin
TOPO IV, IC50: 1.5-2.5 μg/mL
  
HU 331  
Topoisomerase II
Luotonin F  
Topoisomerase II
Topovale 
Topoisomerase I
 
NK 314  
topoisomerase II alpha
8-Chloro-ATP  
Topoisomerase II